A twice-daily tablet regularly used by the NHS could slow or even reverse certain forms of incurable dementia, a study has claimed.
Nilotinib, a blood cancer medicine, was previously shown to improve movement and mental function in a small group of patients with Parkinson’s disease-related dementia and Lewy body dementia during a 2015 trial.
For some patients, the £2,000-a-year drug appeared to even reverse dementia symptoms – with one woman regaining the ability to feed herself and three nonverbal patients speaking again.
Nilotinib, a blood cancer medicine, was previously shown to improve movement and mental function in a small group of patients with Parkinson’s disease-related dementia and Lewy body dementia during a 2015 trial.
For some patients, the £2,000-a-year drug appeared to even reverse dementia symptoms – with one woman regaining the ability to feed herself and three nonverbal patients speaking again.